Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,162.81
(
-0.04%
)
News Focus
News Focus
Post# of 824041
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

KRISGO

Send PM Follow Ignore
Followers 12
Posts 1629
Boards Moderated 0
Alias Born 04/15/2013

KRISGO

Re: manibiotech post# 754096

Thursday, 03/13/2025 6:23:16 PM

Thursday, March 13, 2025 6:23:16 PM

Post# of 824041
Yes, how are they making money without DCVAX-L approved? Or is it from DCVAX-L compassionate care funds? or from other parties? How will this benefit NWBO shareholders?

Advent Bio revenue up 23% between 2022 and 2023, as filed on March 4, 2025.
💪
Revenue is likely from the UK Specials Programme to produce DCVax-L. Can't wait to see the 2024 numbers, as they will likely be significant.
👍
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News